Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

44.05
Delayed Data
As of Feb 17
 +0.90 / +2.09%
Today’s Change
32.18
Today|||52-Week Range
55.15
+13.82%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close43.15
Today’s open42.90
Day’s range42.48 - 44.12
Volume617,977
Average volume (3 months)1,072,436
Market cap$3.8B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)--
Earnings growth (next 5 years)+17.19%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp+0.23+0.22%
BLUEbluebird bio Inc+0.55+0.72%
----
XONIntrexon Corp-0.14-0.59%
Data as of 4:02pm ET, 02/17/2017

Financials

Last reporting dateFebruary 15, 2017
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
President, Chief Operating &
Financial Officer
David-Alexandre C. Gros
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs